Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Cereno Scientific

5.81 SEK

+0.26 %

Less than 1K followers

CRNO B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Cereno Scientific

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue
EBITDA-15.2-26.9-75.6-17.3-16.1-13.4-26.9-73.8
EBIT-15.3-27.1-75.8-17.5-16.3-13.6-27.1-74.6
EBIT-%
Profit before taxes-22.7-40.1-99.5-25.0-26.6-21.3-44.7-117.8
Net income-22.7-40.1-99.5-25.0-26.6-21.3-44.7-117.8
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.